These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38978196)

  • 1. Smell loss is associated with cognitive impairment in amyotrophic lateral sclerosis patients.
    Huang X; Wu J; Zhang N; Teng J; Yang Q; Zhang Y; Yin T; Zhou W; Fan D; Ye S
    CNS Neurosci Ther; 2024 Jul; 30(7):e14851. PubMed ID: 38978196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival.
    Xu Z; Alruwaili ARS; Henderson RD; McCombe PA
    J Neurol Sci; 2017 May; 376():16-23. PubMed ID: 28431606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study.
    Pilotto A; Rossi F; Rinaldi F; Compostella S; Cosseddu M; Borroni B; Filosto M; Padovani A
    Neurodegener Dis; 2016; 16(5-6):411-6. PubMed ID: 27497596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening instruments of cognition: The relation of the mini-mental state examination to the Edinburgh cognitive and behavioural ALS screen in amyotrophic lateral sclerosis.
    Serian A; Finsel J; Ludolph AC; Uttner I; Lulé D
    PLoS One; 2024; 19(6):e0304593. PubMed ID: 38900757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and determinants of language impairment in non-demented amyotrophic lateral sclerosis patients.
    Solca F; Aiello EN; Torre S; Carelli L; Ferrucci R; Verde F; Ticozzi N; Silani V; Monti A; Poletti B
    Eur J Neurol; 2023 Mar; 30(3):606-611. PubMed ID: 36445001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microstructural correlates of Edinburgh Cognitive and Behavioural ALS Screen (ECAS) changes in amyotrophic lateral sclerosis.
    Trojsi F; Caiazzo G; Siciliano M; Femiano C; Passaniti C; Russo A; Bisecco A; Monsurrò MR; Cirillo M; Esposito F; Tedeschi G; Santangelo G
    Psychiatry Res Neuroimaging; 2019 Jun; 288():67-75. PubMed ID: 30987770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation and norming of the Edinburgh Cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS) for three language groups in South Africa.
    Albertyn CH; Hardy A; Bakker LA; Hlangani M; Van Der Walt K; Zeilinga B; Thomas KGF; Heckmann JM
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):532-541. PubMed ID: 35118918
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen.
    Beeldman E; Govaarts R; de Visser M; van Es MA; Pijnenburg YAL; Schmand BA; Raaphorst J
    J Neurol; 2021 Jul; 268(7):2533-2540. PubMed ID: 33547953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edinburgh Cognitive and Behavioural ALS Screen (ECAS)-Italian version: regression based norms and equivalent scores.
    Siciliano M; Trojano L; Trojsi F; Greco R; Santoro M; Basile G; Piscopo F; D'Iorio A; Patrone M; Femiano C; Monsurrò M; Tedeschi G; Santangelo G
    Neurol Sci; 2017 Jun; 38(6):1059-1068. PubMed ID: 28332040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients.
    Watanabe Y; Ogino M; Ichikawa H; Hanajima R; Nakashima K
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):66-72. PubMed ID: 32757854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary comparison between ECAS and ALS-CBS in classifying cognitive-behavioural phenotypes in a cohort of non-demented amyotrophic lateral sclerosis patients.
    Greco LC; Lizio A; Casiraghi J; Sansone VA; Tremolizzo L; Riva N; Solca F; Torre S; Ticozzi N; Filippi M; Silani V; Poletti B; Lunetta C
    J Neurol; 2022 Apr; 269(4):1899-1904. PubMed ID: 34410493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients.
    Aiello EN; Solca F; Greco LC; Torre S; Carelli L; Morelli C; Doretti A; Colombo E; Messina S; Pain D; Radici A; Lizio A; Casiraghi J; Cerri F; Woolley S; Murphy J; Tremolizzo L; Appollonio I; Verde F; Sansone VA; Lunetta C; Silani V; Ticozzi N; Poletti B
    J Neurol; 2023 Aug; 270(8):4090-4095. PubMed ID: 37147520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population.
    Ye S; Ji Y; Li C; He J; Liu X; Fan D
    PLoS One; 2016; 11(5):e0155496. PubMed ID: 27195772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data.
    Pinto-Grau M; Burke T; Lonergan K; McHugh C; Mays I; Madden C; Vajda A; Heverin M; Elamin M; Hardiman O; Pender N
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):99-106. PubMed ID: 27894201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders.
    Niven E; Newton J; Foley J; Colville S; Swingler R; Chandran S; Bak TH; Abrahams S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):172-9. PubMed ID: 25967542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): lack of practice effect in ALS patients?
    Burkhardt C; Neuwirth C; Weber M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):202-209. PubMed ID: 28165766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR).
    Kacem I; Abida Y; Ferchichi W; Mrabet S; Sghaier I; Gharbi A; Souissi A; Nasri A; Gargouri A; Ben Djebara M; Gouider R
    Rev Neurol (Paris); 2022 Oct; 178(8):817-825. PubMed ID: 35570063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).
    Crockford C; Newton J; Lonergan K; Madden C; Mays I; O'Sullivan M; Costello E; Pinto-Grau M; Vajda A; Heverin M; Pender N; Al-Chalabi A; Hardiman O; Abrahams S
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):65-73. PubMed ID: 29214872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis.
    Higashihara M; Pavey N; van den Bos M; Menon P; Kiernan MC; Vucic S
    Neurology; 2021 Apr; 96(16):e2090-e2097. PubMed ID: 33827958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of amyotrophic lateral sclerosis with cognitive and behavioural changes based on a sixty-month longitudinal follow-up.
    Ye S; Jin P; Chen L; Zhang N; Fan D
    PLoS One; 2021; 16(8):e0253279. PubMed ID: 34379621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.